Illumina
the NovaSeq X fleet (890 active installs at end of FY2025) gains a 40% output uplift to 35 billion reads and a Q70 quality score, with DRAGEN pipelines expanded for multi-omics and oncology.
- Country
- United States
- Ticker
- NASDAQ: ILMN
ISO 13485
CE-IVD
Coverage
| CN | EU | US | |
|---|---|---|---|
| bioinformatics-omics | ✓ | ✓ | ✓ |
| diagnostics-medtech | ✓ | ✓ | ✓ |
| monitoring-conservation | ✓ | ✓ | ✓ |
Regulatorsusda-aphismoa-chinaefsaepaademefdaemanmpa
Technologies
| Name | Cluster | Risk | |
|---|---|---|---|
| Bioinformatics & multi-omics | bioinformatics-omics | Low | → |
| Invasive-species biomonitoring via eDNA | monitoring-conservation | Low | → |
| Personalized diagnostics | diagnostics-medtech | Low | → |
| Sovereign genome databases (plants, animals, microbes) | monitoring-conservation | Medium | → |
Compiled by BIOECON via the bioecon-brief pipeline.
Compliance
Bioecon is an information intermediary; it is not a regulator, a certification body, or a legal advisor. When working with public-sector customers (procurement under 44-FZ / 223-FZ), Bioecon acts solely as an independent analytical platform, with no remuneration from suppliers.